Hannah Goulart, MD, discusses the use of first-line blinatumomab plus ponatinib in Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia.
Hannah Goulart, MD
Advertisement
Hannah Goulart, MD, is a hematology oncology fellow at The University of Texas MD Anderson Cancer Center
Articles by Hannah Goulart, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Orca-T for Matched Donor HSCT in Hematologic Malignancies
2
As ADC Options Expand, Sequencing and Toxicity Management Become the Next Challenges in Gynecologic Oncology
3
MANGROVE Trial Shows Improved Efficacy With Zanubrutinib Plus Rituximab vs Chemo in MCL
4
Epcoritamab Plus Lenalidomide Improves PFS vs R-GemOx in R/R DLBCL
5